Evidence map›Paper›PMID 25054046›Full record

ArticleMolecular and clinical oncology2014

Magnetic resonance imaging shrinkage patterns following neoadjuvant chemotherapy for breast carcinomas with an emphasis on the radiopathological correlations.

Kaori Tomida, Mitsuaki Ishida, Tomoko Umeda, Sachiko Sakai, Yuki Kawai, Tsuyoshi Mori, Yoshihiro Kubota, Eiji Mekata, Shigeyuki Naka, Hajime Abe and 2 more

Abstract read
In one paragraph

Article in Molecular and clinical oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Neoadjuvant chemotherapy in oral cancers: Selecting the right patients.Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kaori TomidaDepartments of Surgery, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan.
Mitsuaki IshidaClinical Laboratory Medicine and Division of Diagnostic Pathology, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan.
Tomoko UmedaDepartments of Surgery, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan.
Sachiko SakaiDepartments of Surgery, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan.
Yuki KawaiDepartments of Surgery, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan.
Tsuyoshi MoriDepartments of Surgery, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan.
Yoshihiro KubotaDepartments of Surgery, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan.
Eiji MekataDepartments of Surgery, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan.
Shigeyuki NakaDepartments of Surgery, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan.
Hajime AbeDepartments of Surgery, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan.
Hidetoshi OkabeClinical Laboratory Medicine and Division of Diagnostic Pathology, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan.
Tohru TaniDepartments of Surgery, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Preoperative neoadjuvant chemotherapy (NAC) is considered to be the standard treatment for locally-advanced breast carcinomas. Obtaining precise information regarding the tumor extent and distribution by imaging modalities to assess the success of breast-conserving surgery following NAC is extremely important. Analysis of the detailed radiopathological correlation of magnetic resonance imaging (MRI) following NAC has not been reported previously. The MRI and histopathological shrinkage patterns of residual breast carcinomas in 27 consecutive cases were analyzed following NAC and classified into five categories: Types I and II (concentric shrinkage with and without surrounding lesions, respectively); type III (shrinkage with residual multinodular lesions); type IV (diffuse contrast enhancement in whole quadrant); and non-visualization. The present study clearly demonstrated that the most common MRI shrinkage pattern was type I (11 cases), followed by type II and non-visualization, and the most common histopathological shrinkage pattern was type II (11 cases), followed by type III (8 cases). The concordance rate between MRI and pathological patterns was 48% and the worst concordance MRI pattern was type I. MRI is considered to be a useful method for evaluation of the residual carcinoma following NAC. However, the concordance rate was low in the MRI pattern I cases and tiny foci of residual carcinoma were present in half of the non-visualization cases, as shown by MRI. Therefore, the tumor extent must be completely resected for patients who undergo NAC, and postoperative radiation may be important for preventing local recurrence of breast carcinoma.

Indexed as

breast cancermagnetic resonance imagingneoadjuvant chemotherapyshrinkage pattern

Identifiers

PMID25054046
PMCPMC4106740

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.